Evidence map›Paper›PMID 31680402›Full record

ArticleChembiochem : a European journal of chemical biology2019

Lipidated Stapled Peptides Targeting the Acyl Binding Protein UNC119.

Philipp M Cromm, Hélène Adihou, Shobhna Kapoor, Mercedes Vazquez-Chantada, Paul Davey, David Longmire, Elisabeth Hennes, Walter Hofer, Philipp Küchler, Elisabetta Chiarparin and 2 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Development of a Genetically Encoded and Potent PDE6D Inhibitor.Chembiochem : a European journal of chemical biology · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Lipidated Stapled Peptides Targeting the Acyl Binding Protein UNC119.Chembiochem : a European journal of chemical biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Philipp M CrommDepartment of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.ORCID 0000-0001-5291-3379
Hélène AdihouDepartment of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.
Shobhna KapoorDepartment of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.ORCID 0000-0003-3684-4312
Mercedes Vazquez-ChantadaChemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.
Paul DaveyChemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.
David LongmireChemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.
Elisabeth HennesDepartment of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.
Walter HoferDepartment of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.
Philipp KüchlerDepartment of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.
Elisabetta ChiarparinChemistry, Oncology R&D, AstraZeneca, Darwin Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK.
Herbert WaldmannDepartment of Chemical Biology, Max-Planck-Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227, Dortmund, Germany.
Tom N GrossmannVrije Universiteit Amsterdam, Department of Chemistry and Pharmaceutical Sciences, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands.ORCID 0000-0003-0179-4116

Funding

H2020 European Research Council 678623Studienstiftung des Deutschen Volkes n.a.
6 · The paper itself

Abstract

The acyl-binding UNC119 proteins mediate the activation and transport of various N-myristoylated proteins. In particular, UNC119a plays a crucial role in the completion of cytokinesis. Herein, we report the use of a lipidated peptide originating from the UNC119 binding partner Gnat1 as the basis for the design of lipidated, stabilized α-helical peptides that target UNC119a. By using the hydrocarbon peptide-stapling approach, cell-permeable binders of UNC119a were generated that induced the accumulation of cytokinetic and binucleated cells; this suggests UNC119a as a potential target for the inhibition of cytokinesis.

Indexed as

Lipid MetabolismAdaptor Proteins, Signal TransducingAmino Acid SequenceHeLa CellsHumansModels, MolecularMolecular Targeted TherapyPeptidesProtein BindingProtein Conformation, alpha-HelicalAdaptor Proteins, Signal TransducingPeptidesUNC119 protein, humanalpha-helixesmacrocyclizationpeptidomimeticsprotein-protein interactiontrafficking

Identifiers

PMID31680402
PMCPMC6973269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.